340B and Medicare

A new report from the Berkeley Research Group shows the 340B program is having a huge effect on the cost of Medicare programs. The study shows that 340B markups are costing taxpayers an estimated $13.4 billion a year in lost Medicare rebates. Medicare cannot collect rebates that reduce federal spending when hospitals purchase medicines at the 340B price; when tax-exempt hospitals take advantage of 340B discounts, they pass the cost of Medicare onto taxpayers. Our Health Equity advocates for reforms to the 340B program that prioritize patients over profits and ensure that the system is working the way it should be. Read more here.